aceRNA Technologies

aceRNA Technologies is a Japanese biotechnology company specializing in the development of RNA-based synthetic biological tools for cell therapy and regenerative medicine. The company's core technology involves "RNA switches" that can detect specific intracellular information, such as microRNA activity, to control gene expression or identify specific cell types. This platform enables the high-purity selection of target cells from heterogeneous populations, such as those derived from induced pluripotent stem cells (iPSCs). By integrating these switches into mRNA-based delivery systems, aceRNA Technologies aims to improve the safety and efficacy of next-generation cell and gene therapies.